`
` AO 120 (Rev. 08/10)
`
`TO:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`for the District of Massachusetts
`filed in the U.S. District Court
`on the following
`✔
`G Trademarks or G Patents. ( G the patent action involves 35 U.S.C. § 292.):
`DOCKET NO.
`DATE FILED
`U.S. DISTRICT COURT
`9/27/2018
`for the District of Massachusetts
`DEFENDANT
`Eli Lilly and Company
`
`PLAINTIFF
`Teva Pharmaceuticals International GmbH and
`Teva Pharmaceuticals USA, Inc.
`
`PATENT OR
`TRADEMARK NO.
`8,586,045
`
`DATE OF PATENT
`OR TRADEMARK
`11/19/2013
`
`8,597,649
`
`9,266,951
`
`9,340,614
`
`9,346,881
`
`12/3/2013
`
`2/23/2016
`
`5/17/2016
`
`5/24/2016
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
`HOLDER OF PATENT OR TRADEMARK
`
`Teva Pharmaceuticals International GmbH
`
`Teva Pharmaceuticals International GmbH
`
`Teva Pharmaceuticals International GmbH
`
`Teva Pharmaceuticals International GmbH
`
`Teva Pharmaceuticals International GmbH
`
`(cid:11)(cid:49)(cid:77)(cid:70)(cid:66)(cid:84)(cid:70)(cid:1)(cid:84)(cid:70)(cid:70)(cid:1)(cid:66)(cid:85)(cid:85)(cid:66)(cid:68)(cid:73)(cid:78)(cid:70)(cid:79)(cid:85)(cid:1)(cid:71)(cid:80)(cid:83)(cid:1)(cid:66)(cid:69)(cid:69)(cid:74)(cid:85)(cid:74)(cid:80)(cid:79)(cid:66)(cid:77)(cid:1)(cid:81)(cid:66)(cid:85)(cid:70)(cid:79)(cid:85)(cid:84)(cid:14)(cid:74)(cid:79)(cid:14)(cid:84)(cid:86)(cid:74)(cid:85)(cid:15)(cid:15)
`In the above—entitled case, the following patent(s)/ trademark(s) have been included:
`INCLUDED BY
`
`DATE INCLUDED
`
`PATENT OR
`TRADEMARK NO.
`
`G Amendment
`DATE OF PATENT
`OR TRADEMARK
`
`G Other Pleading
`G Cross Bill
`G Answer
`HOLDER OF PATENT OR TRADEMARK
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
`In the above—entitled case, the following decision has been rendered or judgement issued:
`DECISION/JUDGEMENT
`
`CLERK
`
`(BY) DEPUTY CLERK
`
`DATE
`
`Copy 1—Upon initiation of action, mail this copy to Director Copy 3—Upon termination of action, mail this copy to Director
`Copy 2—Upon filing document adding patent(s), mail this copy to Director Copy 4—Case file copy
`
`
`
`Case 1:18-cv-12029-ADB Document 2 Filed 09/27/18 Page 2 of 2
`
`Teva Pharmaceuticals International GmbH and Teva Pharmaceuticals USA, Inc. v. Eli Lilly and Company
`United States District Court for the District of Massachusetts
`Date of Filing: September 27, 2018
`
`
`Continuation of Patents-in-Suit
`
`Patent No.
`9,884,907
`9,884,908
`9,890,210
`9,890,211
`
`Date of Patent
`2/6/2018
`2/6/2018
`2/13/2018
`2/13/2018
`
`
`
`Holder of Patent
`Teva Pharmaceuticals International GmbH
`Teva Pharmaceuticals International GmbH
`Teva Pharmaceuticals International GmbH
`Teva Pharmaceuticals International GmbH
`
`